Literature DB >> 2873121

Neural antagonists modulate pulmonary vascular pressure-flow plots in conscious dogs.

P A Murray, R F Lodato, J R Michael.   

Abstract

Multipoint pulmonary vascular pressure-cardiac index (P/Q) plots were constructed in conscious dogs during normoxia by graded constriction of the thoracic inferior vena cava to reduce Q. P/Q plots were generated with the autonomic nervous system (ANS) intact and following total autonomic ganglionic block, cholinergic block, and sympathetic alpha- and beta-adrenergic block alone and in combination. With the ANS intact, the relationship between the pulmonary vascular pressure gradient [pulmonary arterial pressure (PAP)--pulmonary capillary wedge pressure (PCWP)] and Q was linear with an extrapolated pressure intercept of 0 mmHg. Total autonomic ganglionic block increased PAP-PCWP over the entire range of Q studied (60-140 ml . min-1 . kg-1). Cholinergic block resulted in a small increase in PAP-PCWP at a Q of 60 ml . min-1 . kg-1, a small decrease in PAP-PCWP at a Q of 140 ml . min-1 . kg-1, but no change in PAP-PCWP over the midrange of Q. Sympathetic beta-adrenergic block increased, and sympathetic alpha-adrenergic block decreased PAP-PCWP over the entire range of Q studied. Combined sympathetic alpha- and beta-adrenergic block also increased PAP-PCWP at each level of Q. Thus the ANS, either directly or via circulating catecholamines, exerts an active regulatory influence on the pulmonary vascular P/Q relationship of intact conscious dogs during normoxia over a wide range of Q. Activation of sympathetic beta-adrenergic receptors results in pulmonary vasodilatation, whereas, alpha-receptor activation results in vasoconstriction. Surprisingly, based on the effects of total autonomic ganglionic block and combined sympathetic alpha- and beta-adrenergic block, the net effect of the ANS on PAP-PCWP/Q during normoxia appears to be pulmonary vasodilatation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873121     DOI: 10.1152/jappl.1986.60.6.1900

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

1.  Exercise-induced pulmonary vasoconstriction during combined blockade of nitric oxide synthase and beta adrenergic receptors.

Authors:  D W Kane; T Tesauro; T Koizumi; R Gupta; J H Newman
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

2.  Halothane inhibits hypoxic pulmonary vasoconstriction in the presence of cyclooxygenase blockade.

Authors:  D Johnson; I Mayers; T Hurst
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

3.  Role of an aprotinin-sensitive protease in the activation of Ca(2+)-ATPase by superoxide radical (O2-.) in microsomes of pulmonary vascular smooth muscle.

Authors:  T Chakraborti; S K Ghosh; J R Michael; S Chakraborti
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

4.  Effects of phenylephrine and ephedrine on pulmonary arterial pressure in patients with cervical or lumbar epidural anesthesia, or enflurane anesthesia.

Authors:  Makoto Tanaka; Shuji Dohi
Journal:  J Anesth       Date:  1994-06       Impact factor: 2.078

5.  Lack of involvement of the autonomic nervous system in early ventilatory and pulmonary vascular acclimatization to hypoxia in humans.

Authors:  Chun Liu; Thomas G Smith; George M Balanos; Jerome Brooks; Alexi Crosby; Mari Herigstad; Keith L Dorrington; Peter A Robbins
Journal:  J Physiol       Date:  2006-11-30       Impact factor: 5.182

6.  Role of matrix metalloprotease-2 in oxidant activation of Ca2+ ATPase by hydrogen peroxide in pulmonary vascular smooth muscle plasma membrane.

Authors:  Malay Mandal; Sudip Das; Tapati Chakraborti; Amritlal Mandal; Sajal Chakraborti
Journal:  J Biosci       Date:  2003-03       Impact factor: 1.826

7.  Role of membrane-associated Ca+ dependent matrix metalloprotease-2 in the oxidant activation of Ca2+Atpase by tertiary butylhydroperoxide.

Authors:  Sudip Das; Tapati Chakraborti; Malay Mandal; Amritlal Mandal; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

8.  Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility.

Authors:  Steffen Rex; Carlo Missant; Patrick Segers; Rolf Rossaint; Patrick F Wouters
Journal:  Intensive Care Med       Date:  2007-08-21       Impact factor: 17.440

Review 9.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.